The U.S. Food and Drug Administration has approved Novartis' oral treatment for patients with type of chronic inflammatory skin disease, the Swiss drugmaker said on Tuesday. The twice-daily pill, ...
The U.S. Food and Drug Administration has approved Novartis' oral treatment for patients with type of chronic inflammatory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback